In the realm of biochemical research and molecular analysis, the kras g12d peptide sequence has become a focal point for investigators studying protein-protein interactions and binding affinities. As someone who follows the development of synthetic molecular tools, I have found the technical specifications of these sequences to be remarkably precise. Understanding the nuances of these short amino-acid sequences is essential for anyone engaged in structural biology or ligand-binding studies.
Technical Specifications and Molecular Composition
The KRAS G12D mutation is a subject of intense scrutiny, primarily due to its role in cellular signaling pathways. When we look at the peptide derivatives of this protein, we must consider the specific amino acid sequence that defines their behavior.
One of the most commonly documented variants is the 9-mer, often identified by the sequence VVVGADGVGK. This specific arrangement has a molecular weight of approximately 9 Selective targeting of oncogenic KRAS G12D using 00.04 Da. Another significant variant is the GADGVGKSAL sequence, which spans amino acids 10-19. This 10-mer has a molecular formula of C36H63N11O14 and a molecular weight of 873.96 Da. Researchers often utilize these sequences as syn Site-directed antibodies targeting driver mutations of the thetic standards to calibrate experimental assays.
Structural Insights and Binding Dynamics
The KRASG12Dpeptide is frequently analyzed in the context of its interaction with HLA molecules and potential inhibitory ligands. For instance, GADGVGKSA is a mutant KRAS G12D 9mer peptide that has been utilized in immunogenic research to understand how neoantigens are presented.
In my review of recent literature, it is fascinating to observe the development of three cyclic peptide ligands of K-Ras(G12D). These cyclic structures, such as the well-known KRpep-2d, demonstrate how structural modifications can significantly enhance selectivity. Unlike linear variants, cyclic peptides often provide a more rigid conformation, which can be advantageous when targeting the specific pocket created by the G12D mutation.
Research Tools and Methodologies
For those setting up laboratory models, the Plasmid pHAGE-KRAS-G12D remains a standard reference tool for expressing the full-length protein in various cell lines. By comparing the behavior of these expressed proteins against synthetic peptides, scientists can validate the specificity of their binding studies.
The Kras G12D Peptide is not just a single entity; it is a family of related molecules that serve as critical building blocks for:
* Surface Plasmon Resonance (SPR) studies: Determining the KRAS G12D Peptide (VVVGADGVGK) kinetic binding constants.
* X-ray Crystallography: Utilizing structures like PDB 7ow6 to map the interaction interface.
* Phage Display Screening: Identifying high-affinity binders t by K Sakamoto·2017·Cited by 156—After subsequentsequenceoptimization, we successfully generated KRpep-2d (Ac-RRRRCPLYISYDPVCRRRR-NH2) that inhibited enzyme activity of K-Ras(G12D) with IC50 Read more hat can distingu KRAS G12D Peptide (GADGVGKSAL) ish between the mutated G12D form and the wild-type protein.
Final Observations
The precision required to synthesize and analyze a G12D-related sequence is a testament to the advancements in modern peptide chemistry. Whether working with the 9-mer or the 10-mer, the consistency of these sequences allows for rigorous, reproducible data collection. As research continues to evolve, the ability to selectively target these mutant segments remains a cornerstone of biochemical inquiry. By focusing on the structural integrity of these short amino-acid sequences, we gain a clearer picture of how molecular switches function at the atomic level, providing a found Identification of peptide inhibitors of KRAS G12D and Q61H ation for future exploration in synthetic biology and beyond.